Skip to content
DataLookout
Menu

NCT04234724

Physiological Effects of ANGPTL3 Variants in Humans

StatusWithdrawn
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 13 versions: 10 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial status changed: Recruiting → Withdrawn Sponsor's reason: COVID pandemic Show 4 more changesShow less
    • Enrollment target: estimated 50 to confirmed 0
    • Eligibility criteria expanded, about 11 words
    • Primary completion date changed from estimate of Jun 30, 2026 to Jun 30, 2021
    • Site details revised
  2. Notable Primary and study completion dates: Jun 30, 2025 to Jun 30, 2026v12
  3. Notable Primary and study completion dates: Jan 1, 2024 to Jun 30, 2025v10
  4. Notable Trial status: Suspended to Recruiting
    • Site details revised
    v7
  5. Minor Start date changed from estimate of Nov 1, 2020 to Dec 1, 2020v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Start date: Sep 1, 2020 to Nov 1, 2020v5
  2. Notable Start date: Jul 1, 2020 to Sep 1, 2020v4
  3. Notable Start date: May 1, 2020 to Jul 1, 2020v3
  4. Stopped Trial status: Not Yet Recruiting to Suspended Sponsor's reason: Suspended due to COVID-19
    • Study sites: 0 to 1
    v2
  1. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

The role of ANGPTL3 on lipid metabolism.
Timeframe: through study completion, an average of 13 weeks
The role of this protein on glucose metabolism.
Timeframe: through study completion, an average of 13 weeks
The role of ANPTL3 on fatty acids
Timeframe: through study completion, an average of 13 weeks

Arms and interventions

VariantExperimental

Volunteers with known ANGPTL3 variants

Non-variantOther

Healthy volunteers with no ANGPTL3 variants

Other: Kinetics test, oral fat tolerance test, and an oral glucose tolerance test.

Sites

1 site in 1 country

  • University of PennsylvaniaPhiladelphia, Pennsylvania, United States